Skip to content
BioCina
  • About Us
    • Our Company
      • About BioCina
      • Our History
      • Mission and Vision
      • Executive Leadership
    • Facilities
      • Adelaide
      • Microbial
      • pDNA
      • mRNA
      • Warehouse
  • Our Services
    • Our Offerings
      • Microbial
      • pDNA
      • mRNA
    • Our Services
      • Technology Transfer
      • Process Development
      • Analytical Development
      • cGMP Manufacturing
      • Quality & Regulatory
  • News, Insights & Resources
    • News
      • Press Releases
      • Events
    • Thought Leadership
      • Research
      • White Papers
    • Resources
      • Videos
      • Fact Sheets
      • Case Studies
  • Careers
    • Join Our Team
      • Career Opportunities
      • Meet Our People
  • Policies
    • Our Policies
      • Quality Policy
      • EHS Policy
      • Privacy Policy
  • Contact Us
BioCina

News

Check Out BioCina’s News Feed

Featured Story

BioCina’s CEO Mark W. Womack Features on Molecule to Market Podcast

June 1, 2024
|
Events,Podcast
Join us as Excellence meets Innovation at BioCina.  Embark on BioCina's CEO, Mark W. Womack's remarkable journey from the US Navy to leading great companies...
  • View All

BioCina and NovaCina Merger Bolsters Global CDMO Industry

January 13, 2025
|
Press Releases
BioCina Chief Executive Officer, Mark W. Womack BioCina Chief Executive Officer, Mark W. Womack [ADELAIDE, SOUTH...
Centivax Selects Global CDMO BioCina to Initiate cGMP Manufacturing

Centivax Selects Global CDMO BioCina to Initiate cGMP Manufacturing of Revolutionary Universal Influenza Vaccine

October 10, 2024
|
Press Releases
Adelaide, South Australia, October 10, 2024/-- BioCina Pty Ltd., a global end-to-end biologics Contract Development and...

EnGeneIC Selects Global CDMO BioCina to Advance Their Ground-Breaking Cancer Treatment

September 24, 2024
|
Press Releases
Adelaide, South Australia, September 25, 2024/ — BioCina Pty Ltd., a global end-to-end biologics Contract Development...

BioCina Acquires the Exclusive CDMO Rights for Leading-Edge Minicircle DNA Technology Platform from CelluTx

June 3, 2024
|
Press Releases
BioCina Acquires the Exclusive CDMO Rights for Leading-Edge Minicircle DNA Technology Platform from CelluTxAdelaide, South Australia,...

Innovative Visionary Mark W. Womack Strengthens Bridgewest Perth Pharma Pty Ltd Board, Amplifying NovaCina’s Growth Vision

March 5, 2024
|
Press Releases
Mark W. Womack Named to Bridgewest Perth Pharma Pty Ltd Board of Directors (Miami and Perth, Australia,...

BioCina and NovaCina Forge Strategic Alliance to Offer Biologics Developers Integrated Drug Substance and Drug Product Solutions

February 27, 2024
|
Press Releases
ADELAIDE, South Australia, and PERTH, Western Australia, Feb. 27, 2024 /PRNewswire/ -- BioCina Pty Ltd., a global end-to-end biologics Contract Development and...

Don't Miss a Beat

Subscribe to Our Email List Today

Subscribe
  • About Us
    • Our Company
      • About BioCina
      • Our History
      • Mission and Vision
      • Executive Leadership
    • Facilities
      • Adelaide
      • Microbial
      • pDNA
      • mRNA
      • Warehouse
  • Our Services
    • Our Offerings
      • Microbial
      • pDNA
      • mRNA
    • Our Services
      • Technology Transfer
      • Process Development
      • Analytical Development
      • cGMP Manufacturing
      • Quality & Regulatory
  • News, Insights & Resources
    • News
      • Press Releases
      • Events
    • Thought Leadership
      • Research
      • White Papers
    • Resources
      • Videos
      • Fact Sheets
      • Case Studies
  • Careers
    • Join Our Team
      • Career Opportunities
      • Meet Our People
  • Policies
    • Our Policies
      • Quality Policy
      • EHS Policy
      • Privacy Policy
  • Contact Us
OUR VISION

To be the most client-centric and reliable Biologics CDMO, accelerating therapies to market and enriching the lives of all stakeholders.

OUR MISSION

We provide everything clients value the most.
We keep our commitments through unrivaled quality and industry-leading on-time and in-full delivery, every step of the way.

About Us

  • Our Company
  • About BioCina
  • Our History
  • Mission and Vision
  • Executive Leadership

  • Facilities
  • Adelaide
  • Microbial
  • pDNA
  • mRNA
  • Warehouse
Our Services

  • Our Offerings
  • Microbial
  • pDNA
  • mRNA

  • Our Services
  • Technology Transfer
  • Process Development
  • Analytical Development
  • cGMP Manufacturing
  • Quality & Regulatory
News, Insights & Resources

  • News
  • Press Releases
  • Events

  • Thought Leadership
  • Research
  • White Papers

  • Resources
  • Videos
  • Facts Sheets
  • Case Studies
Careers

  • Join Our Team
  • Career Opportunities
  • Meet Our People
Policies

  • Our Policies
  • Quality Policy
  • EHS Policy
  • Privacy Policy
Contact Us

© 2025 BioCina. All Rights Reserved.